IN2012DN03157A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03157A
IN2012DN03157A IN3157DEN2012A IN2012DN03157A IN 2012DN03157 A IN2012DN03157 A IN 2012DN03157A IN 3157DEN2012 A IN3157DEN2012 A IN 3157DEN2012A IN 2012DN03157 A IN2012DN03157 A IN 2012DN03157A
Authority
IN
India
Prior art keywords
acceptable salt
pharmaceutical
oxi
cox
inhibitor
Prior art date
Application number
Other languages
English (en)
Inventor
A Folger Martin
Crowley Samuel
Wilson Amy
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of IN2012DN03157A publication Critical patent/IN2012DN03157A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1412—Containers with closing means, e.g. caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352—Polymer or resin containing [i.e., natural or synthetic]
    • Y10T428/1397—Single layer [continuous layer]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IN3157DEN2012 2009-10-12 2010-10-11 IN2012DN03157A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25070909P 2009-10-12 2009-10-12
PCT/US2010/052128 WO2011046853A1 (en) 2009-10-12 2010-10-11 Containers for compositions comprising meloxicam

Publications (1)

Publication Number Publication Date
IN2012DN03157A true IN2012DN03157A (zh) 2015-09-18

Family

ID=43432342

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3157DEN2012 IN2012DN03157A (zh) 2009-10-12 2010-10-11

Country Status (9)

Country Link
US (2) US9101529B2 (zh)
EP (2) EP4378443A2 (zh)
JP (1) JP5559339B2 (zh)
CN (1) CN102647971B (zh)
AU (1) AU2010307096B2 (zh)
CA (1) CA2777366C (zh)
IN (1) IN2012DN03157A (zh)
MX (1) MX2012004177A (zh)
WO (1) WO2011046853A1 (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
WO2007039417A1 (en) * 2005-09-30 2007-04-12 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
EP4378443A2 (en) 2009-10-12 2024-06-05 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
JP2018021002A (ja) * 2016-01-29 2018-02-08 興和株式会社 ロキソプロフェンを含有してなる医薬製剤
FR3080368B1 (fr) * 2018-04-20 2021-04-23 Virbac Dispositif de protection contre les chocs apte a equiper une bouteille
WO2019214715A1 (zh) * 2018-05-11 2019-11-14 南京清普生物科技有限公司 一种美洛昔康组合物、制剂及其制备方法与应用
CN111846514A (zh) * 2019-04-30 2020-10-30 北京蓝丹医药科技有限公司 一种氟比洛芬注射液与容器的组合

Family Cites Families (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2795529A (en) * 1954-06-17 1957-06-11 American Home Prod Stabilized hyaluronidase solution containing calcium chloride
US3288675A (en) * 1964-03-20 1966-11-29 Hoffmann La Roche Parenteral sulfonamide compositions and processes
JPS477352Y1 (zh) 1969-06-13 1972-03-17
BE789726A (fr) * 1971-10-06 1973-04-05 Merck & Co Inc Suppositoires a l'indomethacine
US3931212A (en) * 1973-07-19 1976-01-06 Warner-Lambert Company Method for treating cardiovascular circulatory insufficiencies and hypotonia with 2-hydroxy-phenyl-1-oxa-4-azaspiroalkane derivatives
US3947576A (en) * 1973-09-27 1976-03-30 Mortell Company Synergistic biostatic composition
DE2756113A1 (de) 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
FR2437838A1 (fr) 1978-07-25 1980-04-30 Roecar Holdings Nv Medicament pour le traitement de l'adenome benin de la prostate
JPS56110665A (en) 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
US4543200A (en) * 1983-09-28 1985-09-24 Sherman Laboratories, Inc. Contact lens preservative system cleaner and method
IT1212778B (it) 1983-10-07 1989-11-30 Lisapharma Spa Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
ATE57472T1 (de) * 1984-03-14 1990-11-15 Jerome Corbiere Verfahren zum loesen von wirksubstanzen und auf diese weise erhaltene arzneimittel.
DE3437232A1 (de) 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
IT1196307B (it) 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
IT1207994B (it) 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
NL8600731A (nl) * 1986-03-21 1987-10-16 Dmv Campina Bv Verbeterde gesproeidroogde lactose en werkwijze ter bereiding ervan.
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
US5414011A (en) * 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
EP0306984B1 (en) 1987-09-11 1992-04-15 Syntex (U.S.A.) Inc. Preservative system for ophtalmic formulations
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
JPH02134375A (ja) 1988-09-21 1990-05-23 G D Searle & Co ３―オキシラニル安息香酸およびその誘導体
US5360611A (en) * 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
IL95942A0 (en) 1989-10-13 1991-07-18 Syntex Inc Collagen-containing ophthalmic formulation
KR920002148A (ko) 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
HU205550B (en) * 1990-11-27 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pyroxycam solution of increased stability, free from effects damaging tussues
JP3541849B2 (ja) 1991-04-19 2004-07-14 久光製薬株式会社 消炎鎮痛貼付剤
FR2679135B1 (fr) 1991-07-18 1995-05-19 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation.
IT1251650B (it) 1991-10-29 1995-05-17 Boehringer Ingelheim Italia Composti in incusione di meloxicam con ciclodestrine
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
JP2860729B2 (ja) 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
DE4217971C1 (de) 1992-05-30 1993-10-21 Boehringer Ingelheim Vetmed Verfahren und Wirbelbettapparatur zum Granulieren und/oder Umhüllen
US5455271A (en) 1992-06-18 1995-10-03 The Scripps Research Institute Tight-binding inhibitors of leukotriene A4 hydrolase
US8178516B2 (en) 1992-06-30 2012-05-15 Sylvan Labs, LLC Compositions and method for treatment of chronic inflammatory diseases
US5304561A (en) * 1992-07-24 1994-04-19 Faezeh Sarfarazi New concept in glaucoma treatment
KR0169505B1 (ko) 1992-09-11 1999-01-15 오오쓰끼 아끼히꼬 약제 포장용 폴리올레핀 포장재, 그의 제조방법 및 약제 포장용 용기
US5380934A (en) * 1992-10-29 1995-01-10 Kyowa Hakko Kogyo Co., Ltd. Process for producing alanylgutamine
ES2065846B1 (es) 1993-04-20 1995-10-01 Cusi Lab Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
DE4322826A1 (de) 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
US5676944A (en) 1993-10-06 1997-10-14 The Regents Of The University Of California Ocular therapy with homologous macrophages
US5474985A (en) 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
WO1995018604A1 (en) 1994-01-11 1995-07-13 Ciba-Geigy Ag Topical treatment of ocular photophobia
JP2742333B2 (ja) * 1994-05-06 1998-04-22 アルコン ラボラトリーズ，インコーポレイテッド 眼科用組成物におけるビタミンｅトコフェリル誘導体の使用
US5620999A (en) 1994-07-28 1997-04-15 Weier; Richard M. Benzenesulfonamide subtituted imidazolyl compounds for the treatment of inflammation
US5616601A (en) 1994-07-28 1997-04-01 Gd Searle & Co 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US6506876B1 (en) 1994-10-11 2003-01-14 G.D. Searle & Co. LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5585492A (en) 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
JP3550782B2 (ja) 1995-03-14 2004-08-04 大日本インキ化学工業株式会社 乳酸系ポリエステルの発泡性粒子
US5700816A (en) 1995-06-12 1997-12-23 Isakson; Peter C. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
CN1196679A (zh) 1995-07-19 1998-10-21 麦克公司 结肠腺瘤治疗方法
EP0839029A1 (en) 1995-07-20 1998-05-06 PHARMACIA & UPJOHN COMPANY Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules
EP0866713B1 (en) 1995-11-13 2006-08-02 North-West University Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs
US5686414A (en) 1995-11-14 1997-11-11 Xoma Corporation Methods of treating conditions associated with corneal transplantation
CA2246265A1 (en) 1996-02-13 1997-08-21 G.D. Searle & Co. Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors
WO1997031631A1 (en) 1996-02-27 1997-09-04 Rpms Technology Limited Cox-2 selective inhibitors for managing labour and uterine contractions
EP0934075B1 (en) * 1996-06-20 2002-04-03 Novartis AG Micrococcin atibiotic for the prevention and treatment of mastitis
US6709678B2 (en) * 1996-08-15 2004-03-23 Losan Pharma Gmbh Easy to swallow oral medicament composition
ATA156496A (de) 1996-09-03 1997-10-15 Nycomed Austria Gmbh Pharmazeutische zusammensetzung
US6071539A (en) * 1996-09-20 2000-06-06 Ethypharm, Sa Effervescent granules and methods for their preparation
GB2318511A (en) 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
FR2765898B1 (fr) * 1997-07-10 1999-10-01 Thibierge Et Comar Papier calque de couleur
DE19729879C2 (de) 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
EP1007049A1 (en) 1997-08-27 2000-06-14 Hexal AG New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
JP4936579B2 (ja) 1997-09-05 2012-05-23 第一三共株式会社 ロキソプロフェン含有医薬製剤
EP1017370B1 (en) 1997-09-11 2003-10-29 Nycomed Danmark ApS MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
SE9703693D0 (sv) * 1997-10-10 1997-10-10 Astra Pharma Prod Novel combination
TW492882B (en) * 1997-11-28 2002-07-01 Caleb Pharmaceuticals Inc Cholinergic antagonist plaster composition
ES2205550T3 (es) 1997-12-03 2004-05-01 MERCK & CO., INC. Formulaciones inyectables de accion prolongada que contienen aceite de ricino hidrogenado.
US6136804A (en) * 1998-03-13 2000-10-24 Merck & Co., Inc. Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
EP0945131A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Perorale Wirkstoff-Suspension
EP0945134A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
US6184220B1 (en) * 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
AU754064B2 (en) 1998-05-15 2002-11-07 Wakamoto Pharmaceutical Co., Ltd. Anti-inflammatory eye drops
US6319519B2 (en) * 1998-07-07 2001-11-20 Norton Healthcare Ltd. Anti-inflammatory pharmaceutical formulations
US6106862A (en) * 1998-08-13 2000-08-22 Andrx Corporation Once daily analgesic tablet
PT1109534E (pt) 1998-09-10 2003-06-30 Nycomed Danmark As Composicoes farmaceuticas de farmacos de libertacao rapida
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
US6180136B1 (en) * 1998-11-10 2001-01-30 Idexx Laboratories, Inc. Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use
US6156349A (en) * 1998-12-14 2000-12-05 Steinbach, Pylant And Herman, L.L.C. Method of treating HIV infection with suppository containing mammalian liver extract
US6183779B1 (en) * 1999-03-22 2001-02-06 Pharmascience Inc. Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
US6552020B1 (en) 1999-07-30 2003-04-22 Allergan, Inc. Compositions including antibiotics and methods for using same
US6166012A (en) * 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same
FR2798289B1 (fr) * 1999-09-15 2004-12-31 Cll Pharma Formes galeniques a delitement rapide en bouche et leur procede de preparation
AU1548001A (en) 1999-11-24 2001-06-04 Wakamoto Pharmaceutical Co., Ltd. Ophthalmic aqueous preparation
US6685928B2 (en) * 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
KR200182299Y1 (ko) 1999-12-08 2000-05-15 장지일 플로스 케이스를 포함하는 플로스 홀더
IN191512B (zh) 2000-01-21 2003-12-06 Panacea Biotech
US6689092B2 (en) * 2000-03-03 2004-02-10 Boehringer International Gmbh Needle-less injector of miniature type
DE10010123A1 (de) 2000-03-03 2001-09-20 Boehringer Ingelheim Int Nadelloser Injektor in Miniaturausführung
EP1292381B1 (en) * 2000-05-03 2009-07-15 D'SILVA, Joe Process and device for producing liquid dosage formulations
AU2001259974A1 (en) * 2000-05-15 2001-11-26 Merck Frosst Canada & Co Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
DE10024752A1 (de) 2000-05-16 2001-11-29 Ben Pfeifer Mittel und Vorrichtung zur Behandlung von Prostata-Erkrankungen
WO2001089519A1 (en) * 2000-05-22 2001-11-29 Nitromed, Inc. Thromboxane inhibitors, compositions and methods of use related applications
DE10030345A1 (de) 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10032132A1 (de) 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
US20020077328A1 (en) * 2000-07-13 2002-06-20 Fred Hassan Selective cyclooxygenase-2 inhibitors and vasomodulator compounds for generalized pain and headache pain
ES2223209B1 (es) * 2001-12-11 2005-10-01 Esteve Quimica, S.A. Nuevas formas cristalinas del meloxicam y procedimientos para su preparacion e interconversion.
GB0022215D0 (en) 2000-09-11 2000-10-25 Boehringer Ingelheim Pharma Method for the treatment of thromboembolic disorders in patients with aspirin« resistance
DE10300323A1 (de) * 2003-01-09 2004-10-14 Baxter Healthcare S.A. Sicherheitsbehälter mit erhöhter Bruch und Splitterfestigkeit sowie kontaminationsfreier Außenfläche für biologisch aktive Substanzen und Verfahren zu deren Herstellung
US20040204413A1 (en) * 2001-01-26 2004-10-14 Joaquina Faour Pharmaceutical compositions containing a COX-II inhibitor and a muscle relaxant
WO2002078625A2 (en) * 2001-03-28 2002-10-10 Pharmacia Corporation Therapeutic combinations for cardiovascular and inflammatory indications
EP1250921A1 (en) 2001-04-21 2002-10-23 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Fast disintegrating meloxicam tablet
US20020187187A1 (en) * 2001-04-21 2002-12-12 Toshimitsu Ohki Fast disintegrating meloxicam tablet
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
WO2003029411A2 (en) * 2001-09-28 2003-04-10 Brigham Young University Novel cyclooxygenase variants and methods of use
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EP1348436A1 (en) 2002-03-30 2003-10-01 Boehringer Ingelheim International GmbH Meloxicam suppositories
US20040001883A1 (en) * 2002-03-30 2004-01-01 Boehringer Ingelheim International Gmbh Meloxicam suppositories
US20040024042A1 (en) * 2002-04-02 2004-02-05 Vanderbilt University COX2 inhibition in the prevention and treatment of autosomal dominant polycystic kidney disease
DE10223013A1 (de) 2002-05-22 2003-12-04 Boehringer Ingelheim Int Verwendung von Meloxicam für die Linderung von Organverletzungen während Organoperation oder -transplantation
AU2003244913A1 (en) 2002-07-09 2004-01-23 B.M.R.A. Corporation B.V. Pharmaceutical combination of a thromboxane A2 receptor antagonist and a COX-2 inhibitor
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
CA2499093A1 (en) 2002-09-17 2004-04-01 Nippon Boehringer Ingelheim Co., Ltd. Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer.
WO2004026116A2 (en) 2002-09-19 2004-04-01 The Regents Of The University Of California Use of etodoclac to treat hyperplasia
US20040171611A1 (en) * 2002-09-30 2004-09-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline acetic acid solvate of meloxicam
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
DE10250081A1 (de) 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
CA2413705A1 (en) * 2002-12-06 2004-06-06 Raul Altman Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions
US20050197332A1 (en) * 2002-12-10 2005-09-08 Boehringer Ingelheim International Use of meloxicam in combination with an antiplatelet agent for treatment of acute coronary syndrome and related conditions
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
WO2004078113A2 (en) * 2003-03-04 2004-09-16 Pharmacia Corporation Treatment and prevention of obesity with cox-2 inhibitors alone or in combination with weight-loss agents
US20040214753A1 (en) * 2003-03-20 2004-10-28 Britten Nancy Jean Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
US20040198826A1 (en) * 2003-04-07 2004-10-07 Boehringer Ingelheim International Gmbh Pharmaceutical combination for treating benign prostatic hyperplasia or for treating abacterial prostatitis
DE10315702A1 (de) 2003-04-07 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Arzneitmittelkombinationen zur Behandlung von gutartiger Prostatahyperplasie oder zur Behandlung von abakterieller Prostatitis
JP4018022B2 (ja) 2003-04-10 2007-12-05 株式会社ホシモト 開閉用ハンドル装置
WO2004103283A2 (en) 2003-05-14 2004-12-02 Pharmacia Corporation Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damage
CL2004001293A1 (es) 2003-05-29 2005-05-06 Schering Plough Ltd Composicion farmaceutica que comprende compuestos antibacterianos como florfenicol, tiamfenicol, cloramfenicol en combinacion con al menos un portador seleccionado de triacetina, dimetilacetamida o una mezcla de ellas; y su uso en el tratamiento de u
US20050038018A1 (en) * 2003-07-09 2005-02-17 Boehringer Ingelheim International Gmbh Meloxicam compositions
WO2005004915A2 (en) 2003-07-09 2005-01-20 Boehringer Ingelheim International Gmbh Compositions comprising meloxicam
US20050147664A1 (en) * 2003-11-13 2005-07-07 Elan Pharma International Ltd. Compositions comprising antibodies and methods of using the same for targeting nanoparticulate active agent delivery
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
AU2005230732A1 (en) * 2004-04-08 2005-10-20 Idd-Eal Manufacturing Company Limited Container for constituting a formulation in liquid form
DE102004021281A1 (de) 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004025324A1 (de) 2004-05-19 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Flüssige Zubereitung für die Veterinärmedizin, Verfahren zu deren Herstellung und deren Verwendung
DE102004030409A1 (de) 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
PT1824493E (pt) * 2004-12-06 2008-11-18 Janssen Pharmaceutica Nv Suspensão oral que compreende meloxicam
WO2006100213A1 (en) 2005-03-23 2006-09-28 Boehringer Ingelheim International Gmbh Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor
JP4929448B2 (ja) 2005-07-29 2012-05-09 財団法人ヒューマンサイエンス振興財団 断層撮影装置
MXPA05010505A (es) * 2005-09-29 2007-03-28 Leopoldo Espinosa Abdala Forma farmaceutica que contiene metocarbamol, meloxicam y betametasona.
WO2007039417A1 (en) * 2005-09-30 2007-04-12 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
DE602006012732D1 (de) * 2005-12-20 2010-04-15 Basell Poliolefine Srl El
US20070187405A1 (en) 2006-01-23 2007-08-16 Pujara Chetan P Container for compositions containing cefdinir
US20070249727A1 (en) * 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
JP4321624B2 (ja) 2007-05-21 2009-08-26 株式会社デンソー 半導体素子駆動回路
FR2917381B1 (fr) 2007-06-15 2009-10-16 Ceva Sante Animale Sa Conditionnement plastique multicouche pour la conservation d'une composition pharmaceutique
WO2009049304A1 (en) * 2007-10-12 2009-04-16 Map Pharmaceuticals, Inc. Inhalation drug delivery
GB0724707D0 (en) 2007-12-19 2008-01-30 Burke Michael H A process for the preparation of an orally administered unit dose tablet
EP4378443A2 (en) 2009-10-12 2024-06-05 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
US20110218191A1 (en) 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets

Also Published As

Publication number Publication date
US9101529B2 (en) 2015-08-11
EP4378443A2 (en) 2024-06-05
CA2777366C (en) 2023-11-14
AU2010307096B2 (en) 2014-07-03
JP2013507440A (ja) 2013-03-04
CN102647971A (zh) 2012-08-22
US9186296B2 (en) 2015-11-17
AU2010307096A1 (en) 2012-04-19
MX2012004177A (es) 2012-05-08
JP5559339B2 (ja) 2014-07-23
EP2488145B1 (en) 2024-04-24
US20130161228A1 (en) 2013-06-27
CA2777366A1 (en) 2011-04-21
US20110083985A1 (en) 2011-04-14
WO2011046853A1 (en) 2011-04-21
CN102647971B (zh) 2016-03-16
EP2488145A1 (en) 2012-08-22

Similar Documents

Publication Publication Date Title
IN2012DN03157A (zh)
IL244858A0 (en) Molecular conjugates of fumarate and fatty acid, pharmaceutical preparations containing them and their uses
EP2604260A4 (en) NOVEL HETEROCYCLIC DERIVATIVES, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
IL210246A0 (en) Carboxylic acid compounds and pharmaceutical containing the same
IL222548A (en) Hydroxamic acid derivatives and their antimicrobial and antimicrobial preparations
IL214236A0 (en) Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
IL216405A (en) Pharmaceutical preparation containing melphalan and cyclodextrin derivative and used for drug preparation
EP2588106A4 (en) DELAYED RELEASED PHARMACEUTICAL COMPOSITION WITH PRAMIPEXOL OR A PHARMACEUTICALLY ALLOWED SALT AND INCREASED STABILITY
BR112013016160A2 (pt) sistema de um recipiente para armazenar e dispensar um produto e uma máquina para dosar o produto
HK1181389A1 (zh) 包含酰胺衍生物或其可藥用鹽的藥物組合物
IL218644A0 (en) Pharmaceutical composition having the active substances metformin and sitaglipin or vildagliptin
EP2523666B8 (en) A pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one with improved storage and solubility properties
EP2777713A4 (en) MEDICAMENTOUS CONJUGATE OF AMINO ACID-IRINOTECAN ACID POLYETHYLENE GLYCOL-OLIGOPEPTIDE AND DRUG COMPOSITION THEREOF
EP2468771A4 (en) PHARMACEUTICAL COMPOSITION WITH AN ANTIBODY TO HB-EGF AS AN ACTIVE SUBSTANCE
EP2618816A4 (en) AEROSOL COMPOSITION FOR THE ADMINISTRATION OF MEDICAMENTS
IL226003A0 (en) Derivation of trans-2-decenoic acid and a pharmaceutical agent containing it
IL225105A (en) Heterocyclic compounds, their process, their pharmaceutical preparations and their use in the preparation of drugs
IL218008A (en) Dexbinol or its salt for non-melanoma cancer suppression, its use in the preparation of non-melanoma cancer suppressant, and a pharmacological preparation containing the said
HK1149012A1 (en) Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
HK1123998A1 (en) Pharmaceutical preparation containing garcinia acid and use thereof
EP2438076A4 (en) TARGETED MEDICAMENTAL OUTPUT IN BONES
HK1171234A1 (zh) 二苯硫醚衍生物和含有其作為活性成分的藥物
IL221737A (en) Its compound or salt, a pharmaceutical preparation containing it and its uses
EP2445895A4 (en) DITHIOCTATE OF PIPERAZINE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
ZA201303252B (en) Liposomal drug composition containing a polymeric guanidine deravitive